Zhitong Finance App News, Tasly (600535.SH) issued an announcement. Recently, the company received approval from the State Drug Administration (hereinafter referred to as the “State Drug Administration”) to issue a “Pharmaceutical Clinical Trial Approval Notice” for TDX105 granules.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.